Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 173.10
-10.80 (-5.87%)
Sep 10, 2026, 11:59 AM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 16.63 billion as of September 9, 2026. Its market cap has decreased by -53.09% in one year.
Market Cap
16.63B
Enterprise Value
13.57B
Revenue
972.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
173.10
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has decreased from 17.51B to 16.63B, a decrease of -5.03%. That is a compound annual growth rate of -3.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 16.63B | -37.61% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 23.42B |
| Zai Lab | 23.09B |
| Metis TechBio | 20.78B |
| HBM Holdings | 12.62B |
| Ascentage Pharma Group International | 12.58B |
| Nanjing Leads Biolabs | 12.35B |
| Everest Medicines | 11.62B |
| Ascletis Pharma | 10.75B |